BSE Live
Jul 31, 16:01Prev. Close
5.10
Open Price
5.10
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jul 31, 15:40Prev. Close
4.95
Open Price
5.25
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Profit & Loss account of Vivimed Labs (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| INCOME | ||||||
| Revenue From Operations [Gross] | 116.27 | 149.07 | 187.10 | 236.57 | 841.22 | |
| Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue From Operations [Net] | 116.27 | 149.07 | 187.10 | 236.57 | 841.22 | |
| Total Operating Revenues | 116.27 | 149.07 | 187.10 | 237.29 | 861.47 | |
| Other Income | 4.37 | 9.98 | 0.97 | 1.27 | 9.82 | |
| Total Revenue | 120.64 | 159.05 | 188.07 | 238.56 | 871.29 | |
| EXPENSES | ||||||
| Cost Of Materials Consumed | 57.76 | 89.55 | 187.09 | 153.00 | 357.82 | |
| Purchase Of Stock-In Trade | 5.67 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating And Direct Expenses | 1.98 | 16.47 | 17.55 | 28.06 | 185.15 | |
| Changes In Inventories Of FGWIP And Stock In Trade | -3.58 | -18.07 | 84.42 | 0.49 | -3.29 | |
| Employee Benefit Expenses | 28.39 | 34.16 | 32.67 | 36.22 | 189.75 | |
| Finance Costs | 2.95 | 2.43 | 35.90 | 39.76 | 53.88 | |
| Depreciation And Amortisation Expenses | 20.22 | 19.94 | 108.41 | 18.28 | 55.50 | |
| Other Expenses | 39.09 | 54.57 | 52.68 | 27.58 | 102.36 | |
| Total Expenses | 152.49 | 199.04 | 518.72 | 303.39 | 941.15 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | -31.85 | -39.99 | -330.65 | -64.83 | -69.86 | |
| Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Profit/Loss Before Tax | -31.85 | -39.99 | -330.65 | -64.83 | -69.86 | |
| Tax Expenses-Continued Operations | ||||||
| Current Tax | 0.23 | 0.00 | 0.00 | 0.00 | 3.37 | |
| Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax | -0.11 | -0.40 | -2.12 | 2.82 | -1.34 | |
| Other Direct Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Tax Expenses | 0.11 | -0.38 | -2.12 | 2.82 | 2.03 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | -31.96 | -39.62 | -328.53 | -67.65 | -71.89 | |
| Profit/Loss From Continuing Operations | -31.96 | -45.45 | -328.53 | -67.65 | -71.89 | |
| Profit/Loss For The Period | -31.96 | -45.45 | -328.53 | -67.65 | -71.89 | |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Consolidated Profit/Loss After MI And Associates | -31.96 | -45.45 | -328.53 | -67.65 | -71.89 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| EARNINGS PER SHARE | ||||||
| Basic EPS (Rs.) | -4.00 | -5.00 | -40.00 | -8.00 | -9.00 | |
| Diluted EPS (Rs.) | -4.00 | -5.00 | -40.00 | -8.00 | -8.00 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
| Equity Share Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
24.06.2025
Vivimed Labs Standalone March 2025 Net Sales at Rs 22.58 crore, down 37.95% Y-o-Y
03.06.2025
Vivimed Labs Consolidated March 2025 Net Sales at Rs 25.61 crore, down 33.67% Y-o-Y
04.03.2025
Vivimed Labs Consolidated December 2024 Net Sales at Rs 36.51 crore, down 11.94% Y-o-Y
16.02.2024
Vivimed Labs Standalone December 2023 Net Sales at Rs 37.14 crore, down 26.55% Y-o-Y
24.06.2025
Vivimed Labs Standalone March 2025 Net Sales at Rs 22.58 crore, down 37.95% Y-o-Y
03.06.2025
Vivimed Labs Consolidated March 2025 Net Sales at Rs 25.61 crore, down 33.67% Y-o-Y
04.03.2025
Vivimed Labs Consolidated December 2024 Net Sales at Rs 36.51 crore, down 11.94% Y-o-Y
16.02.2024
Vivimed Labs Standalone December 2023 Net Sales at Rs 37.14 crore, down 26.55% Y-o-Y